We are live on ! Find out more
SRA

Summit Rock Advisors Portfolio holdings

AUM $16M
This Fund
S&P 500
This Quarter Est. Return
+6.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$167M
AUM Growth
-$1.16M
Cap. Flow
-$10.6M
Cap. Flow %
-6.34%
Top 10 Hldgs %
100%
Holding
8
New
3
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
VTV icon
Vanguard Value ETF
VTV
+$9.41M
2
DAWN
Day One Biopharmaceuticals
DAWN
+$681K
3
MNDY icon
monday.com
MNDY
+$573K
4
DYN icon
Dyne Therapeutics
DYN
+$490K

Top Sells

Rank Stock Value
1
IWN icon
iShares Russell 2000 Value ETF
IWN
+$21.8M

Sector Composition

Rank Sector Weight
1 Healthcare 1.45%
2 Technology 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTV icon
1
Vanguard Value ETF
VTV
$188B
$60.9M 36.37%
413,962
+65,885
+19% +$9.41M
IUSV icon
2
iShares Core S&P US Value ETF
IUSV
$27.1B
$56.5M 33.75%
740,195
– –
IWN icon
3
iShares Russell 2000 Value ETF
IWN
$14.4B
$47.1M 28.12%
283,472
-130,580
-32% -$21.8M
CLOV icon
4
Clover Health Investments
CLOV
$2.5B
$784K 0.47%
210,639
– –
PHAT icon
5
Phathom Pharmaceuticals
PHAT
$920M
$671K 0.4%
34,100
– –
DAWN
6
DELISTED
Day One Biopharmaceuticals
DAWN
$558K 0.33%
+33,125
New +$681K
MNDY icon
7
monday.com
MNDY
$3.1B
$517K 0.31%
+1,676
New +$573K
DYN icon
8
Dyne Therapeutics
DYN
$3.81B
$415K 0.25%
+34,887
New +$490K

Similar funds

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
PA
Prossimo Advisors San Luis Obispo, California $16.4M AUM 14% 1-Year Est. Return
PA
PPM America Chicago, Illinois $16.6M AUM 31.99% 1-Year Est. Return
BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GMP
Great Mountain Partners New Haven, Connecticut $15.1M AUM 92.9% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Summit Rock Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Summit Rock Advisors held 8 positions worth $167M, down 0.69% from $169M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Summit Rock Advisors withdrew a net $10.6M in Q4 2021, reducing 1 holding. Its largest reduction was iShares Russell 2000 Value ETF, cutting an estimated $21.8M.

By sector, the portfolio is most concentrated in Healthcare at 1.5% of assets, down from 1.6% a quarter earlier, followed by Technology.

Against the trend, Summit Rock Advisors opened a new position in Day One Biopharmaceuticals worth $558K.

  • Summit Rock Advisors's largest Q4 2021 buy was Day One Biopharmaceuticals: 33,125 shares worth $558K.
  • Summit Rock Advisors added most to Vanguard Value ETF in Q4 2021, an estimated $9.41M increase.
  • Summit Rock Advisors's biggest Q4 2021 reduction was iShares Russell 2000 Value ETF, cutting an estimated $21.8M.
  • Summit Rock Advisors's ten largest holdings make up 100% of its $167M portfolio in Q4 2021.
  • Summit Rock Advisors opened 3 new positions and closed 0 in Q4 2021.
  • Summit Rock Advisors's portfolio value fell 0.69% quarter-over-quarter to $167M.

Based on Summit Rock Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.